Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
about
Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinomaMolecular biology of Barrett's adenocarcinoma.Chromosomes, 11Q and cancer: a review.Strategies for molecular intervention in esophageal cancers and their precursor lesions.Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinomaUbiquitin-dependent proteolysis in G1/S phase control and its relationship with tumor susceptibilityPlasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma.Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to ChinaPrognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinomaComparative genomic hybridization analysis of genetic aberrations associated with development of esophageal squamous cell carcinoma in Henan, China.Genomic biomarkers for molecular imaging: predicting the futureProapoptotic and Antiproliferative Effects of Thymus caramanicus on Human Breast Cancer Cell Line (MCF-7) and Its Interaction with Anticancer Drug Vincristine.Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.Molecular mechanisms of curcumin action: gene expression.The 11q13-q14 amplicon: clinicopathological correlations and potential drivers.Tissue microarray analysis of cyclin D1 gene amplification and gain in colorectal carcinomas.Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.In silico dissection of miRNA targetome polymorphisms and their role in regulating miRNA-mediated gene expression in esophageal cancer.The radiation-sensitizing effect of flavopiridol in the esophageal cancer cell line Eca109.Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma.Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review.Upregulation of SYF2 in esophageal squamous cell carcinoma promotes tumor cell proliferation and predicts poor prognosis.Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation.Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry.Clinical impact of predicting CCND1 amplification using plasma DNA in superficial esophageal squamous cell carcinoma.New Development of Oncogenetics—High Throughput Tissue Microarray Technology
P2860
Q28296721-782CF74C-FC00-4943-B89C-B54CA90E5077Q30327935-BA827802-D414-4007-AECB-0AE051B38A06Q33643315-43136717-4B81-4ED9-85BA-B4E54C6A94DBQ33815320-CF60922A-5EBD-4332-8802-8814CD8DCF10Q33834440-FE9012E0-798E-4D20-8C3E-96F4BF738AB7Q34346963-0EF24F37-53B0-4AEA-8527-D6C47C466322Q34354560-2DBA37AA-F14F-4FC4-A2FA-2A642F4FD61AQ35108381-E9B5C772-B32C-4BD9-B004-AC69264DD3C7Q35151103-3F50E164-D158-4F48-B85A-B3254A907A65Q36134992-838D7291-37A6-4E05-A30A-371414813539Q36294947-F48CFC26-585A-4E49-B676-DC186F9BF32CQ37237671-F1BD9492-F553-4305-92A0-02B67764AF72Q37508283-511E77EA-7724-4D0C-A008-4F9A9624D652Q37724945-EC312C3C-B56B-4AF0-B8C7-425A42436675Q37960201-CF523F94-9D75-47AE-B6D7-1A38BD29B26FQ38045211-F4CF2B4C-B851-427A-B806-4044510114FFQ38066149-5E4115CB-B8E8-462C-BB2B-3384EDC0698AQ38333991-96686FB6-3228-4F1F-9718-708895983126Q38383917-F58FE72D-30D3-4BA3-9C67-0CED67BBB605Q38831897-2E36155F-DDB0-4121-A88C-025683B35CA9Q39129076-D6520165-C2CD-4B71-AF1D-781061B037BEQ39167703-8D8FFBEE-4351-46D5-9FF9-17AF263B7040Q40383603-FEDEE50B-6C6E-4100-A6AE-0B1129A2AC27Q41017427-7F8F6667-7CB0-4614-B76F-2F6E52581F19Q43482671-EE5E16D4-1F08-43E8-AE2D-1BAB23DDE217Q47843768-296BAFE4-F0DB-496A-B10E-19C51C096ED7Q52863799-80C054CA-554C-451E-B676-4DDAABC06E97Q52996581-089F1276-AB2C-4E63-958A-9A218E0355D0Q53070828-CD214E70-B1E2-4E2A-AF13-421E27638B5DQ58050657-236CBCF6-DCA4-42B8-B790-FB8569EA5FD0
P2860
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
@en
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
@nl
type
label
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
@en
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
@nl
prefLabel
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
@en
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
@nl
P2093
P2860
P356
P1476
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
@en
P2093
P2860
P2888
P356
10.1038/BJC.1995.13
P407
P577
1995-01-01T00:00:00Z